RE:RE:RE:RE:RE:RE:RE:Maybe NEWS MARCH 1st.......SZLS Without any doubt I prefer dual listing with a stock that has low share float like SZLS. More means to trade a stock and easier to keep it liquid.
That's what apealing right now is they only have less than 61 millions shares, for a bio company it's nice if they can keep it that way until they join NASDAQ. If they need to finance another PP, now with all the attention they got and with the positive cashflow from COVID revenu, it's easier to get a higher shareprice value financing minimizing the dillution of the stock if any dillution at all :-)
Some of you scream for a news but in past experience I prefer less news with important informations than lots of news and no important informations. I always had mistrust on company that release frequent news, I prefer less frequent but more pertinent news. So far SZLS is doing the smart thing and focusing on their work and not on news, we are not a news company :-) Tripp is smart, right now it's not the time to inform the competitor of the advancement of Aristotle, when he's ready then we all know at once including the competition.
Have a nice and safe weekend.